STEVEN I SHERMAN to Vascular Endothelial Growth Factor Receptor-2
This is a "connection" page, showing publications STEVEN I SHERMAN has written about Vascular Endothelial Growth Factor Receptor-2.
Connection Strength
0.188
-
ONC201 Shows Potent Anticancer Activity Against Medullary Thyroid Cancer via Transcriptional Inhibition of RET, VEGFR2, and IGFBP2. Mol Cancer Ther. 2021 04; 20(4):665-675.
Score: 0.167
-
Biomarkers as predictors of response to treatment with motesanib in patients with progressive advanced thyroid cancer. J Clin Endocrinol Metab. 2010 Nov; 95(11):5018-27.
Score: 0.020